Trial Profile
A Double-Blind, Placebo-Controlled Study of Silodosin to Facilitate Urinary Stone Passage
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Jan 2016
Price :
$35
*
At a glance
- Drugs Silodosin (Primary)
- Indications Ureteral calculi
- Focus Therapeutic Use
- Sponsors Actavis Inc
- 09 May 2014 New trial record
- 08 Aug 2013
- 05 Jul 2012